Pharma & Biotech Inside Biotech: Percheron maps out phase II push for next-generation VISTA inhibitor By Proactive 19/02
Hardware & electrical equipment Tech Bytes: Life360 expands Uber tie-up with in-app ride tracking and teen account integration By Proactive 18/02
Investments and investor services Britons say they need nearly £9,000 in cash before opening Stocks and Shares ISA, research finds By Proactive 16/02
Financial Services Tech Bytes: ASX tech bounces — but the ‘AI rerate’ isn’t done yet By Proactive 16/02
Financial Services Three things to watch in the week ahead: AU unemployment, BHP & JB Hi-Fi's earnings By Proactive 16/02
Medical technology & services Inside Biotech: Heavyweights feel the heat as results season bites By Proactive 13/02
Pharma & Biotech Inside Biotech: Trial tweaks, TGA clearance and US site openings headline busy day for biotechs By Proactive 11/02
Blockchain & Crypto Bit Digital a strategic crypto play amid volatility, Noble Capital analysts say By Proactive 09/02
Pharma & Biotech Why precision oncology may be poised for a reset: a conversation with Sona Nanotech By Proactive 09/02